These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 24125427)
1. Prevalence and determinants of metabolically healthy obesity in Spain. Lopez-Garcia E; Guallar-Castillon P; Leon-Muñoz L; Rodriguez-Artalejo F Atherosclerosis; 2013 Nov; 231(1):152-7. PubMed ID: 24125427 [TBL] [Abstract][Full Text] [Related]
2. Variable patterns of obesity and cardiometabolic phenotypes and their association with lifestyle factors in the Di@bet.es study. Gutiérrez-Repiso C; Soriguer F; Rojo-Martínez G; García-Fuentes E; Valdés S; Goday A; Calle-Pascual A; López-Alba A; Castell C; Menéndez E; Bordiú E; Delgado E; Ortega E; Pascual-Manich G; Urrutia I; Mora-Peces I; Vendrell J; Vázquez JA; Franch J; Girbés J; Castaño L; Serrano-Ríos M; Martínez-Larrad MT; Catalá M; Carmena R; Gomis R; Casamitjana R; Gaztambide S Nutr Metab Cardiovasc Dis; 2014 Sep; 24(9):947-55. PubMed ID: 24984822 [TBL] [Abstract][Full Text] [Related]
3. Metabolic normality in overweight and obese subjects. Which parameters? Which risks? Pataky Z; Makoundou V; Nilsson P; Gabriel RS; Lalic K; Muscelli E; Casolaro A; Golay A; Bobbioni-Harsch E Int J Obes (Lond); 2011 Sep; 35(9):1208-15. PubMed ID: 21206481 [TBL] [Abstract][Full Text] [Related]
4. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Wildman RP; Muntner P; Reynolds K; McGinn AP; Rajpathak S; Wylie-Rosett J; Sowers MR Arch Intern Med; 2008 Aug; 168(15):1617-24. PubMed ID: 18695075 [TBL] [Abstract][Full Text] [Related]
5. Serum magnesium in the metabolically-obese normal-weight and healthy-obese subjects. Guerrero-Romero F; Rodriguez-Moran M Eur J Intern Med; 2013 Oct; 24(7):639-43. PubMed ID: 23523313 [TBL] [Abstract][Full Text] [Related]
6. The prevalence of metabolically healthy obese subjects defined by BMI and dual-energy X-ray absorptiometry. Shea JL; Randell EW; Sun G Obesity (Silver Spring); 2011 Mar; 19(3):624-30. PubMed ID: 20706202 [TBL] [Abstract][Full Text] [Related]
7. Body fat percentage is associated with cardiometabolic dysregulation in BMI-defined normal weight subjects. Shea JL; King MT; Yi Y; Gulliver W; Sun G Nutr Metab Cardiovasc Dis; 2012 Sep; 22(9):741-7. PubMed ID: 21215604 [TBL] [Abstract][Full Text] [Related]
8. Obesity in Spanish schoolchildren: relationship with lipid profile and insulin resistance. Garcés C; Gutierrez-Guisado J; Benavente M; Cano B; Viturro E; Ortega H; de Oya M Obes Res; 2005 Jun; 13(6):959-63. PubMed ID: 15976136 [TBL] [Abstract][Full Text] [Related]
9. Body composition determinants of metabolic phenotypes of obesity in nonobese and obese postmenopausal women. Peppa M; Koliaki C; Papaefstathiou A; Garoflos E; Katsilambros N; Raptis SA; Hadjidakis DI; Dimitriadis GD Obesity (Silver Spring); 2013 Sep; 21(9):1807-14. PubMed ID: 23696298 [TBL] [Abstract][Full Text] [Related]
10. Increased oxidative stress in normal-weight postmenopausal women with metabolic syndrome compared with metabolically healthy overweight/obese individuals. Kim M; Paik JK; Kang R; Kim SY; Lee SH; Lee JH Metabolism; 2013 Apr; 62(4):554-60. PubMed ID: 23142163 [TBL] [Abstract][Full Text] [Related]
11. Metabolically obese normal weight and phenotypically obese metabolically normal youths: the CASPIAN Study. Kelishadi R; Cook SR; Motlagh ME; Gouya MM; Ardalan G; Motaghian M; Majdzadeh R; Ramezani MA J Am Diet Assoc; 2008 Jan; 108(1):82-90. PubMed ID: 18155992 [TBL] [Abstract][Full Text] [Related]
12. Identifying metabolically healthy but obese individuals in sedentary postmenopausal women. Messier V; Karelis AD; Prud'homme D; Primeau V; Brochu M; Rabasa-Lhoret R Obesity (Silver Spring); 2010 May; 18(5):911-7. PubMed ID: 19851302 [TBL] [Abstract][Full Text] [Related]
13. Metabolically-healthy obesity and coronary artery calcification. Chang Y; Kim BK; Yun KE; Cho J; Zhang Y; Rampal S; Zhao D; Jung HS; Choi Y; Ahn J; Lima JA; Shin H; Guallar E; Ryu S J Am Coll Cardiol; 2014 Jun; 63(24):2679-86. PubMed ID: 24794119 [TBL] [Abstract][Full Text] [Related]
14. Obesity and metabolic phenotypes (metabolically healthy and unhealthy variants) are significantly associated with prevalence of elevated C-reactive protein and hepatic steatosis in a large healthy Brazilian population. Shaharyar S; Roberson LL; Jamal O; Younus A; Blaha MJ; Ali SS; Zide K; Agatston AA; Blumenthal RS; Conceição RD; Santos RD; Nasir K J Obes; 2015; 2015():178526. PubMed ID: 25838943 [TBL] [Abstract][Full Text] [Related]
15. Cardiovascular risk factors in obese women and their first-degree relatives. Saraç F; Ozgen AG; Yilmaz C; Tüzün M Anadolu Kardiyol Derg; 2007 Dec; 7(4):371-7. PubMed ID: 18065331 [TBL] [Abstract][Full Text] [Related]
16. Persistent high prevalence of cardiovascular risk factors in the urban middle class in India: Jaipur Heart Watch-5. Gupta R; Sharma KK; Gupta A; Agrawal A; Mohan I; Gupta VP; Khedar RS; Guptha S J Assoc Physicians India; 2012 Mar; 60():11-6. PubMed ID: 22799108 [TBL] [Abstract][Full Text] [Related]
17. One third of the variability in HDL-cholesterol level in a large dyslipidaemic population is predicted by age, sex and triglyceridaemia: The Paris La Pitié Study. Hansel B; Kontush A; Giral P; Bonnefont-Rousselot D; Chapman MJ; Bruckert E Curr Med Res Opin; 2006 Jun; 22(6):1149-60. PubMed ID: 16846548 [TBL] [Abstract][Full Text] [Related]
18. Body mass index classification misses subjects with increased cardiometabolic risk factors related to elevated adiposity. Gómez-Ambrosi J; Silva C; Galofré JC; Escalada J; Santos S; Millán D; Vila N; Ibañez P; Gil MJ; Valentí V; Rotellar F; Ramírez B; Salvador J; Frühbeck G Int J Obes (Lond); 2012 Feb; 36(2):286-94. PubMed ID: 21587201 [TBL] [Abstract][Full Text] [Related]
19. Prevalence of metabolic syndrome among Filipino adults aged 20 years and over. Tanchoco CC; Cruz AJ; Duante CA; Litonjua AD Asia Pac J Clin Nutr; 2003; 12(3):271-6. PubMed ID: 14505989 [TBL] [Abstract][Full Text] [Related]
20. The metabolically healthy but obese phenotype is associated with lower plasma levels of persistent organic pollutants as compared to the metabolically abnormal obese phenotype. Gauthier MS; Rabasa-Lhoret R; Prud'homme D; Karelis AD; Geng D; van Bavel B; Ruzzin J J Clin Endocrinol Metab; 2014 Jun; 99(6):E1061-6. PubMed ID: 24606089 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]